The Board of Directors of Zhejiang Hisoar Pharmaceutical Co., Ltd. has authorized a buyback plan on February 2, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.93 CNY | -0.50% | +7.62% | -17.52% |
Apr. 18 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Apr. 01 | Tranche Update on Zhejiang Hisoar Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.52% | 1.32B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Zhejiang Hisoar Pharmaceutical Co., Ltd. authorizes a Buyback Plan.